Varian

The holiday season can be a difficult time for patients undergoing cancer treatment, but the holiday spirit - filled with love, hope, and support - can make a world of difference. Thank you to clinicians, like Daniel Vacca, MSc and their team at Fundación Valle del Lili, who go the extra mile to bring holiday joy into the treatment room for patients and their families.

A new study from Cliniques universitaires Saint-Luc examines the potential benefits of online adaptive radiotherapy (oART) for patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma - a rare type of slow-growing cancer that develops in the stomach's inner lining.   In this paper, researchers were able to reduce PTV margins from a standard 12mm used in non-adaptive therapy, down to just 4mm by using a breath-hold oART methodology. This resulted in significantly reduced doses to organs-at-risk and the normal tissue surrounding the target; an important goal in improving outcomes for radiotherapy patients. https://bit.ly/4g8MYuJ 

The Varian team was excited to be present for this week's ribbon cutting ceremony at Henry Ford Health as they celebrated the installation of their new MR system from Siemens Healthineers. Congratulations!   This ceremony marks an important step in their goal of implementing MRI into the radiation oncology workflow. You can learn more about why the team at Henry Ford Health is so passionate about the use of MR along the cancer treatment pathway by visiting our recent blog: https://bit.ly/3BFLkSC

We’re thrilled to announced that Varian has received U.S. FDA 510(k) clearance covering our RapidArc Dynamic solution. Read the press release: https://bit.ly/3ZZLFc6 RapidArc Dynamic represents a radical transformation in planning and delivery, unlocking new possibilities to plan complex cases in less time, and improve plan quality, while reducing dose to organs at risk.

This liver cancer survivor's story is a powerful example of how interventional radiology techniques such as microwave ablation can offer hope and give new options to patients when surgery isn't the optimal course of action.

For many veterinary radiation oncologists, finding time to do treatment planning can be difficult, with many working on plans after hours to ensure patients can get timely treatment. Varian’s Veterinary Dosimetry Services provides fully remote, treatment planning services, from CT simulation to patient treatment, enabling clinicians to focus on patient care. https://bit.ly/41IYI2K

A recent article from Endovascular Today explores the current methods used in liver ablation, and how cutting-edge technologies such as the IntelliBlate Microwave Ablation system could expand treatment guidelines and improve outcomes for patients with liver tumors. Read more at: https://bit.ly/3ZJlqXb

In the latest episode of the BackTable Podcast, Dr. Edward Kim shares expert insights on the latest advancements in microwave ablation technology and how evolving tools are helping physicians deliver precise, reproducible results. We're proud to support this critical dialogue in #InterventionalRadiology. Listen to the full episode for a closer look at innovations pushing the field forward.

Varian was thrilled to host Minister Jamie Moses, Manitoba Minister of Business, Mining, Trades and Job Creation at our Winnipeg office!     As Minister Moses toured our workplace, we were delighted to share not only the deep history of Varian in #Manitoba, but also how the current work of our dedicated #Winnipeg team is pioneering cancer care technology for the province and beyond.   As a Siemens Healthineers company, we are deeply committed to supporting Manitoba's healthcare goals and improving patient outcomes, and we recognize the role that job growth must play in meeting rising healthcare burdens.

A recent study by Amsterdam UMC explored the potential of daily online adaptive radiotherapy (oART) for bladder cancer to limit high-dose exposure of healthy tissue, compared to conventional non-adaptive radiotherapy.   The paper examines a bladder cancer patient treated after cystoscopic tumor resection to 40 Gy in 20 sessions, with a simultaneous boost of 15 Gy to the tumor bed. By utilizing daily online adaptation the treatment plan, the team was able to achieve smaller planning target volume margins. This reduced the dose to normal healthy tissues in the bladder and bowel, while maintaining 100% coverage of the target region.   The figure shown highlights the difference in dose exposure of the small bowel in the worst non-adaptive radiotherapy case compared to the online adaptive radiotherapy treatment plan. For the full study: https://bit.ly/4fCRiT2